American Glaucoma Society Position Paper: Microinvasive Glaucoma Surgery - PubMed (original) (raw)

doi: 10.1016/j.ogla.2019.12.003.

Cynthia Mattox 2, Kuldev Singh 3, Brian Flowers 4, Brian A Francis 5, Alan L Robin 6, Michelle R Butler 1, Manjool M Shah 6, JoAnn A Giaconi 5, Arsham Sheybani 7, Brian J Song 8, Joshua D Stein 9

Affiliations

American Glaucoma Society Position Paper: Microinvasive Glaucoma Surgery

Ronald L Fellman et al. Ophthalmol Glaucoma. 2020 Jan-Feb.

Abstract

In 2018, the American Glaucoma Society (AGS), the world’s largest professional society of glaucoma subspecialists, convened a 12-member task force of experts to craft a position statement about microinvasive glaucoma surgery (MIGS). The main objective of this position statement is to provide a succinct overview of these procedures and to address some misconceptions about MIGS. The members of the task force were selected by the AGS Board of Directors and include AGS members with expertise in developing MIGS, teaching MIGS, performing research on use and outcomes of these procedures, and working with the United States Food and Drug Administration (FDA) and other regulatory agencies about developing criteria to evaluate the efficacy and safety of these devices. Each of the sections of the position statement was prepared by subgroups of the task force, and then the material from the various sections was aggregated, and the leader of the task force (J.D.S.) merged the material into a cohesive draft. This draft was shared with the AGS Executive Committee and other members of the AGS Board of Directors for additional input.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Flowchart showing different types of microinvasive and traditional glaucoma surgical options along with their respective Current Procedure Terminology billing codes. These codes are accurate as of January 2020 but may be subject to change. #Withdrawn from market. *Not approved by the United States Food and Drug Administration. ABic = ab interno canaloplasty; GATT = gonioscopy-assisted transluminal trabeculotomy; TM = trabecular meshwork.

References

    1. Friedman DS, Wolfs RC, O’Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122(4):532–538. -PMC -PubMed
    1. Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119(12):1819–1826. -PubMed
    1. Varma R, Wang D, Wu C, et al. Four-year incidence of open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study. Am J Ophthalmol. 2012;154(2):315–325.e1. -PMC -PubMed
    1. Stein JD, Kim DS, Niziol LM, et al. Differences in rates of glaucoma among Asian Americans and other racial groups, and among various Asian ethnic groups. Ophthalmology. 2011. June;118(6):1031–1037. -PMC -PubMed
    1. Hennessy AL, Katz J, Covert D, et al. A video study of drop instillation in both glaucoma and retina patients with visual impairment. Am J Ophthalmol. 2011;152(6):982–988. -PubMed

Publication types

MeSH terms

LinkOut - more resources